Model
Edge
Virpax Pharmaceuticals Inc.
VRPX
Filing Type
10-K
Filing Date
3/25/2024
Updated
3/26/24, 2:15 AM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2023
EX-4.4
DESCRIPTION OF SECURITIES
EX-10.38
EMPLOYMENT AGREEMENT, DATED APRIL 7, 2021, BY AND BETWEEN VIRPAX PHARMACEUTICALS, INC. AND SHEILA MATHIAS
EX-10.39
INDEMNIFICATION AGREEMENT, DATED MARCH 25, 2024, BY AND BETWEEN VIRPAX PHARMACEUTICALS, INC. AND VINAY SHAH
EX-19.1
INSIDER TRADING POLICY
EX-21.1
LIST OF SUBSIDIARIES
EX-23.1
CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FINANCIAL STATEMENTS OF VIRPAX PHARMACEUTICALS, INC
EX-31.1
CERTIFICATION
EX-31.2
CERTIFICATION
EX-32.1
CERTIFICATION
EX-32.2
CERTIFICATION
EX-97.1
CLAWBACK POLICY
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic